Global Intravenous Fluids Bags Market 2016-2020
About IV Fluids Bags
Intravenous solutions contain amino acids, dextrose, mineral salts, vitamins, and trace elements, and therefore cover the basic essential components (carbohydrates, proteins, fats, water, electrolytes, vitamins, and minerals) required to build tissue, for energy expenditure, and other physiological activities. A complete mixture of all vital nutrients is also available in multi-chamber bags, which are gaining immense popularity.
Technavio’s analysts forecast the global IV fluids bags market to grow at a CAGR of 10.16% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global IV fluids bags market 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IV fluid bags.The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global IV Fluids Bags Market 2016-2020
Technavio recognizes the following companies as the key players in the global IV fluids bags market: B. Braun Melsungen, Baxter, Hospira, and SIPPEX.
Other prominent vendors in the market are: Amcor, DiaMedicalUSA, Fresenius Kabi, JW Life Science, MRK Healthcare, Minigrip, Nipro, Renolit, Smith Medical, Terumo, Technoflex SA, and Wipak.
Commenting on the report, an analyst from Technavio’s team said: “Trend observed in the market is rising preference for enteral nutrition. Parenteral nutrition is directed through veins, wherein the risk of infection due to needle stick injuries is high. Whereas, enteral nutrition is rendered directly to the gastrointestinal tract. Parenteral nutrition is prescribed only in cases of intestinal failure and is ineffective in patients with a short bowel.”
According to the report, Driver observed in the market is increased risk of malnutrition among cancer patients. Nutrition plays a major role in several aspects of cancer development and eventual treatment. Malnutrition is a common problem in individuals with cancer, and is recognized as an important component for adverse consequences, including increased morbidity and mortality and decreased the quality of life. Weight loss has been identified as an indicator of poor prognosis in cancer patients. It has been noted that at the time of diagnosis, 60% of individuals with lung cancer and 80% of those with upper gastrointestinal cancer have already experienced significant weight loss, generally defined as at least a 10% loss of body weight in a span of six months.
Further, the report states that Challenge observed in the market is counterfeiting of IV fluid bags. Counterfeiting has become a major issue for most of the businesses globally. According to WHO, more than 8% of all the medical devices and related products circulated worldwide are counterfeited. Counterfeiting not only results in major losses for the company but also destroys the brand image of the products. The increasing cases of counterfeit products being supplied in the market has led to a concern among the consumers and the governing authorities around the world. The South East Asian markets have more reports of counterfeit products being sold compared to any other market for fluid bags.
B. Braun Melsungen, Baxter, Hospira, SIPPEX, Amcor, DiaMedicalUSA, Fresenius Kabi, JW Life Science, MRK Healthcare, Minigrip, Nipro, Renolit, Smith Medical, Terumo, Technoflex SA, Wipak.